重组人VSIG4(含V-set和Ig结构域蛋白4)

特别提示：包括重组人VSIG4(含V-set和Ig结构域蛋白4)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人VSIG4(含V-set和Ig结构域蛋白4)
英文名称：Recombinant Human V-Set and Immunoglobulin Domain-Containing Protein 4

产品货号：重组人VSIG4(含V-set和Ig结构域蛋白4)
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Arg20-Pro283在C端含有His标签。

VSIG4质量控制：＞95%(还原性SDS-PAGE)

VSIG4制剂：冻干品

VSIG4保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

VSIG4复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于VSIG4：
V-Set and Immunoglobulin Domain-Containing Protein 4 (VSIG4) is a 45-50 kDa macrophage-specific transmembrane glycoprotein that belongs to the B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type Ig domain and a truncated C-type Ig domain. VSIG4 is abundantly expressed in several fetal tissues. In adult tissues, the highest expression of VSIG4 is in lung and placenta. It is also expressed in resting macrophages. No VSIG4 expression appears to be present in T and B cells. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. VSIG4 is a phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. It is a potent inhibitor of the alternative complement pathway convertases. Human VSIG4 is 399 amino acids (aa) in length. It is a type I transmembrane (TM) glycoprotein that contains a 264 aa extracellular domain (ECD) (aa 20 - 283) and a 95 aa cytoplasmic region.

除了重组人VSIG4(含V-set和Ig结构域蛋白4),，我公司还供应以下相关产品：
 

货号	名称	规格
JN0325	重组小鼠趋化因子CCL9(MIP-1γ)	10μg|50μg|500μg|1mg
JN0348	重组人白介素IL-1F10(白细胞介素1F10)	10μg|50μg|500μg|1mg
JN0397	重组人白介素7受体α( IL-7Rα)	10μg|50μg|500μg|1mg
JN0445	重组人TNFRSF10B(TRAILR2)	10μg|50μg|500μg|1mg
JN1970	重组人子宫球蛋白相关蛋白1(UGRP1)	10μg|50μg|500μg|1mg
JN0603	重组人补体因子H相关蛋白2(CFHR2)	10μg|50μg|500μg|1mg
JN0761	重组人HMGB3(高迁移率族蛋白B3)	10μg|50μg|500μg|1mg
JN0922	重组人α-Parvin(PARVA)	10μg|50μg|500μg|1mg
JN0983	重组人ZIK1	10μg|50μg|500μg|1mg
JN1030	重组人泛素结合酶E2-V1(UBCE2V1)	10μg|50μg|500μg|1mg
JN1071	重组人LMCD1(含LIM结构域及半胱氨酸富集蛋白1)	10μg|50μg|500μg|1mg
JN1090	重组人神经细胞粘附分子(NRCAM)(神经细胞黏附分子)	10μg|50μg|500μg|1mg
JN1123	重组人蛋白质二硫键异构酶A3(PDIA3)	10μg|50μg|500μg|1mg
JN1134	重组人生长激素释放因子(GHRH)	10μg|50μg|500μg|1mg
JN1278	重组人MERTK(酪氨酸蛋白激酶Mer)	10μg|50μg|500μg|1mg
JN1308	重组小鼠Reg2(胰岛再生蛋白2)	10μg|50μg|500μg|1mg
JN1311	重组人神经调节蛋白-1β(NRG-1β)	10μg|50μg|500μg|1mg
JN1374	重组小鼠IL-15RA	10μg|50μg|500μg|1mg
JN1460	重组小鼠TGF-beta RII(C端带Fc标签)	10μg|50μg|500μg|1mg
JN1601	重组人ACOX1	10μg|50μg|500μg|1mg
JN1610	重组人视黄醇结合蛋白5(CRBP-III)(RBP5)	10μg|50μg|500μg|1mg
JN1617	重组小鼠VISTA(B7-H5)	10μg|50μg|500μg|1mg
JN1687	重组人Cathepsin L(组织蛋白酶L)	10μg|50μg|500μg|1mg
ZN1550	人AKt1/active重组蛋白	100ng
ZN1609	人CXCL10重组蛋白	100ng
ZN1639	人HSP27重组蛋白	100ng
ZN1758	小鼠FAS重组蛋白	100ng
ZN1783	小鼠MIP-1α重组蛋白	100ng